Ranbaxy Laboratories has announced its unaudited results for the quarter ended September 2009.
The company has reported a net profit of Rs 186.08 crore for the July-September 2009 quarter, as against net loss of Rs 352.93 in the September 2008 quarter.
Total operating income of the company for the quarter under consideration stood at Rs 1365.19 crore against Rs 1202.22 crore in the year-ago period, up by 13.56% on a year-on-year (YoY) basis.